Background: A previous randomized controlled trial showed higher tibial migration and more device-related complications in bicruciate-retaining compared to cruciate-retaining total knee arthroplasty, raising concerns about long-term implant stability and prompting this follow-up study to assess migration patterns and clinical outcomes up to 7.5 years postoperatively.

Methods: In this follow-up study, the bicruciate-retaining group from an initial single-centre randomized controlled trial was monitored at 5 and 7.5 years postoperatively. Implant migration was measured through model-based radiostereometric analysis and reported as total translation and rotation for femoral and tibial components. Clinical outcomes, including multiple patient-reported outcomes and functional assessments, were also evaluated.

Findings: A total of 13 bicruciate-retaining patients participated in this follow-up study, with 12 completing the 7.5-year follow-up. At 5 and 7.5 years postoperatively, the median(interquartile range) total translation and total rotation for the tibial components were 0.24 mm (0.18-0.48) and 0.59° (0.46-1.10) and 0.30 mm (0.18-0.81) and 0.73° (0.50-1.39), respectively. For the femoral components, total translation and total rotation were 0.46 mm (0.34-0.64) and 0.43° (0.25-0.69) at 5 years, and 0.43 mm (0.24-0.74) and 0.36° (0.30-0.83) at 7.5 years. Clinical and functional outcome scores, on average, were high but one patient reported mediolateral instability.

Interpretation: Migration patterns for both bicruciate-retaining components generally stabilized from 2 to 7.5 years postoperatively, although some outliers show migration of >0.2 mm. Given the high frequency of device-related adverse events and potential healthy survivor bias, these findings do not support the routine clinical use of this implant.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clinbiomech.2025.106473DOI Listing

Publication Analysis

Top Keywords

follow-up study
12
75 years postoperatively
12
total translation
12
implant stability
8
total
8
total knee
8
knee arthroplasty
8
radiostereometric analysis
8
randomized controlled
8
controlled trial
8

Similar Publications

Introduction: This study aimed to identify predictive factors for long-term incomplete nidus obliteration following stereotactic radiosurgery (SRS) for brain arteriovenous malformations (AVMs).

Material And Methods: A systematic search across the PubMed, Web of Science, and Scopus databases identified observational studies reporting such factors. Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines were followed.

View Article and Find Full Text PDF

Objectives: Extracorporeal shock wave lithotripsy (ESWL) with endotherapy (ET) is the first-line treatment in patients with chronic pancreatitis (CP) and main pancreatic duct stone (PDS). Our study aimed to evaluate factors that predict the outcome of ESWL in CP patients with PDS.

Methods: We retrospectively analyzed data of 166 patients with CP and radiopaque PDS.

View Article and Find Full Text PDF

Background: Trachoma, a neglected tropical disease, remains a significant public health concern in many regions, particularly in sub-Saharan Africa and in Yobe State, Nigeria. One approach for elimination involves administering tetracycline eye ointment (TEO) to children <6 months of age as part of annual mass drug administration (MDA), aligning with the World Health Organization's 'A' component of the SAFE (Surgery, Antibiotics, Facial hygiene and Environmental sanitation) strategy for elimination of trachoma as a public health problem. However, suboptimal compliance rates in affected populations pose challenges, potentially serving as a reservoir for reinfection and hindering progress toward trachoma elimination.

View Article and Find Full Text PDF

Lisocabtagene maraleucel (liso-cel) and axicabtagene ciloleucel (axi-cel) are FDA- and EMAapproved chimeric antigen receptor (CAR) T-cell therapies for relapsed/refractory large B-cell lymphoma (LBCL). However, comparative real-world analyses of their efficacy and toxicity with extended follow-up are lacking. We conducted a retrospective study of 160 LBCL patients treated at the Fred Hutchinson Cancer Center with commercial liso-cel or axi-cel per standard of care.

View Article and Find Full Text PDF

Background: Systemic lupus erythematosus (SLE) is a multifaceted autoimmune disorder that significantly impacts renal function. Despite conventional treatments, morbidity and mortality remain high, necessitating the exploration of safer and more effective therapies, including the potential benefits of Traditional Chinese Medicine (TCM) for improving kidney health and survival rates.

Methods: Patients with newly diagnosed with SLE with catastrophic illness certificate were retrospectively enrolled from CGRD between 2005 and 2020.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!